BofA/Merrill Lynch Downgrades Vitamin Shoppe (VSI) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Wedbush Trims Estimates on Vitamin Shoppe (VSI)
February 26, 2013 3:41 PM ESTWedbush today maintained a Neutral rating on Vitamin Shoppe (NYSE: VSI) and trimmed its price target to $54.00 (from $59.00). This morning, Vitamin Shoppe reported Q4 results, which were below estimates due to the impacted from hurricane Sandy.
Commenting on the results, analyst Kurt Frederick... More
Vitamin Shoppe (VSI) Reports In-Line Q4 EPS of 40c; Guides FY13 Comps
February 26, 2013 6:27 AM ESTVitamin Shoppe (NYSE: VSI) reported Q4 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $218.9 million versus the consensus estimate of $223.88 million.
Comparable store sales grew 5.2%, includes an estimated 1.6% negative impact from Superstorm Sandy- E-commerce revenues increased... More
